Estradiol for the prevention of cardiovascular disease?

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Tamoxifen beyond 5 years the new path to prevention?

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?: A Synthesis of the Available Evidence

By Salpeter Shelley R.  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2025-2033

Adis International

Access to resources Recommend Favorite

Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination for hypertension: getting to the point of BP control?

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite